Trial intelligence / Profile preview

Prospective study comparing quality of life between opioid-sparing protocol and WHO guideline in metastatic bone cancer

TCTR20180503005Phase 1Recruiting

Sponsor
The Medical Association of Thailand
Start
Jan 2018
Countries
1
01

Overview

Phase 1 trial in bone cancer (2 arms), sponsored by The Medical Association of Thailand. Primary endpoint: Quality of life. Started Jan 2018; status: recruiting.

02

Conditions

bone cancer

Beyond the preview

Go deeper on TCTR20180503005.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on TCTR20180503005.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call